Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

European Heart Journal Open, 2023
Circulating proteins and peripheral artery disease risk: observational and Mendelian randomization analyses

Yuan S., Titova O., Zhang K. et al.

Olink Target 96CVDPathophysiologyPlasma

Microbiome, 2023
Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection

Wang Z., Peters B., Bryant M. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologySerum

Biomedicines, 2023
Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection

Du Y., Khera T., Liu Z. et al.

Olink Target 96Infectious DiseasesHepatologyPathophysiologyPlasma

JNCI: Journal of the National Cancer Institute, 2023
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

Feng X., Wu W., Onwuka J. et al.

Olink Target 96OncologyPatient StratificationPlasmaSerum

eBioMedicine, 2023
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis

Feng X., Muller D., Zahed H. et al.

Olink Target 96OncologyPatient StratificationBlood

Environment International, 2023
Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease

Dunder L., Salihovic S., Lind P. et al.

Olink Target 96Environmental Health & ToxicologyPathophysiologyPlasma

Frontiers in Molecular Neuroscience, 2023
Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder

Bao X., Chen B., Liu J. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Cell Reports Medicine, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

Diray-Arce J., Fourati S., Doni Jayavelu N. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

American Journal of Physiology-Heart and Circulatory Physiology, 2023
Characterization of a robust mouse model of heart failure with preserved ejection fraction

Matsiukevich D., Kovacs A., Li T. et al.

Olink Target 96 MouseCVDPathophysiologySerum

Circulation: Heart Failure, 2023
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Girerd N., Levy D., Duarte K. et al.

Olink Target 96CVDPatient StratificationPlasma

Scandinavian Journal of Medicine & Science in Sports, 2023
Association of muscular strength and targeted proteomics involved in brain health in children with overweight/obesity

Olvera‐Rojas M., Plaza‐Florido A., Solis‐Urra P. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma

Scientific Reports, 2023
Metagenomic sequencing of human cardiac tissue reveals Microbial RNA which correlates with Toll-like receptor-associated inflammation in patients with heart disease

Sandstedt J., Vukusic K., Dellgren G. et al.

Olink Target 96CVDPathophysiologyPlasma

, 2023
Delineating the effect of sex hormone intake on immunity in cis and trans women with HIV

Pasin C., Nuñez D., Kusejko K. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPatient StratificationPlasma

Neurobiology of Disease, 2023
Uncovering a neurological protein signature for severe COVID-19

El-Agnaf O., Bensmail I., Al-Nesf M. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPatient StratificationPlasma

Clinical Rheumatology, 2023
Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis

Zhang P., Li M., Zhang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal of Clinical Immunology, 2023
Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options

Rodari M., Cazals-Hatem D., Uzzan M. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma

The American Journal of Human Genetics, 2023
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics

Iakovliev A., McGurnaghan S., Hayward C. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Frontiers in Immunology, 2023
Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Li M., Zhang Y., Zhang W. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Thrombosis Research, 2023
Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification

Pallares Robles A., ten Cate V., Lenz M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Scientific Reports, 2023
Age-dependent differences and similarities in the plasma proteomic signature of postoperative delirium

Oren R., Kim E., Leonard A. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

3478 publications